Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program

Go back to Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
(NASDAQ: TRVI) Delayed: 18.26 -0.39 (2.09%)
Previous Close $18.65    52 Week High
Open $18.65    52 Week Low
Day High $18.82    P/E N/A 
Day Low $18.10    EPS
Volume 869,023